Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan

BACKGROUND: Generic antidepressants are approved on the market based on evidence of bioequivalence to their brand-name versions. We aimed to assess whether generic antidepressants exert equal effectiveness as their brand-name counterparts for treating patients with depressive disorders. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chih-Wei, Lee, Sheng-Yu, Yang, Yao-Hsu, Wang, Liang-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061123/
https://www.ncbi.nlm.nih.gov/pubmed/32598470
http://dx.doi.org/10.1093/ijnp/pyaa041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061123/
https://www.ncbi.nlm.nih.gov/pubmed/32598470
http://dx.doi.org/10.1093/ijnp/pyaa041

Ejemplares similares